DSGN (DSGN) Stock Price & Analysis
DSGN (DSGN) rose 0.00% to USD 11.78 as of July 25, 2026 at 03:05 UTC, according to Nexqual real-time market data.
DSGN last closed at USD 11.78; the session ranged USD 11.37–12.08 on volume of 402,253 shares. Market capitalization is —, with a 52-week range of USD 3.76–17.25 (NMS). Source: Nexqual, July 25, 2026 at 03:05 UTC.
Key Statistics (as of July 25, 2026 at 03:05 UTC)
| Price | USD 11.78 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.78 |
| Open | USD 11.78 |
| Day Range | USD 11.37 – 12.08 |
| 52-Week Range | USD 3.76 – 17.25 |
| Volume | 402,253 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (DSGN)
Nexqual's technical model rates DSGN "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.65 (neutral) |
| vs SMA50 | Below (USD 12.44) |
| MACD | -0.29 (negative) |
Earnings (DSGN)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD -0.34 |
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.29 vs est -0.33 ▲ beat |
| 2025-12-31 | USD -0.27 vs est -0.35 ▲ beat |
| 2025-09-30 | USD -0.3 vs est -0.34 ▲ beat |
| 2025-06-30 | USD -0.34 vs est -0.33 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Financials & Fundamentals (DSGN)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -31.26% |
| Debt / Equity | 1.25 |
| Current Ratio | 22.28 |
| Total Cash | $222.82M |
| Total Debt | $2.73M |
| Free Cash Flow | $-31.56M |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Ownership (DSGN)
| Insider Ownership | +31.93% |
|---|---|
| Institutional Ownership | +62.12% |
| Shares Outstanding | 62.46M |
| Float | 32.87M |
| Short % of Float | +12.13% |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
From DSGN's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | USD 17.1 | ▼ 3.12% |
| EWTX | Edgewise Therapeutics, Inc. | USD 40.84 | ▲ 6.55% |
| IMCR | Immunocore Holdings plc | USD 35 | ▼ 1.52% |
| FHTX | Foghorn Therapeutics Inc. | USD 4.85 | ▼ 6.91% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 22.78 | ▼ 4.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:05 UTC. This page is informational and not investment advice.